Kumaran Deiva est neuro-pédiatre à l’hôpital Bicêtre (AP-HP).
Références :
- Scientific Session 2 : Demyelinating disorders in childhood and adolescence. Ectrims 2024.
- Hacoben Y et al. Treatment strategies in pediatric onset MS.
- O010. Sharmin S et al. Long-term disability outcomes among children with multiple sclerosis treated with high-efficacy therapy.
- O011. Pozzilli V. Slowly expanding lesions in pediatrics MS.
- O012. Kotulska-Jozwiak K et al. Ocrelizumab dose selection for treatment of paediatric relapsing-remitting multiple sclerosis: Pharmacokinetic, safety, and efficacy results from OPERETTA 1 (NCT04075266).
- Armangue T et al. Diagnostic challenges in pediatric onset demyelinating diseases.
- O013. Kim NN et al. Pediatric MOG antibody associated autoimmune encephalitis
